Champions Oncology (CSBR) Revenue & Revenue Breakdown
Champions Oncology Revenue Highlights
Main Segment (Y)
Pharmacology Services
Champions Oncology Revenue by Period
Champions Oncology Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-04-30 | - | -100.00% |
| 2023-04-30 | $53.87M | 9.69% |
| 2022-04-30 | $49.11M | 19.66% |
| 2021-04-30 | $41.04M | 27.76% |
| 2020-04-30 | $32.12M | 18.68% |
| 2019-04-30 | $27.07M | 33.72% |
| 2018-04-30 | $20.24M | 31.34% |
| 2017-04-30 | $15.41M | 37.82% |
| 2016-04-30 | $11.18M | 26.16% |
| 2015-04-30 | $8.86M | -23.26% |
| 2014-04-30 | $11.55M | 39.75% |
| 2013-04-30 | $8.27M | 15.61% |
| 2012-04-30 | $7.15M | 3.88% |
| 2011-04-30 | $6.88M | 40.65% |
| 2010-04-30 | $4.89M | 31.89% |
| 2009-04-30 | $3.71M | 165.01% |
| 2008-04-30 | $1.40M | 100.00% |
| 2007-04-30 | - | 100.00% |
| 2006-04-30 | - | -100.00% |
| 2005-04-30 | $1.80M | -10.10% |
| 2004-04-30 | $2.00M | -0.36% |
| 2003-04-30 | $2.01M | -5.72% |
| 2002-04-30 | $2.13M | -3.72% |
| 2001-04-30 | $2.21M | 1.55% |
| 2000-04-30 | $2.18M | -1.06% |
| 1999-04-30 | $2.20M | -5.58% |
| 1998-04-30 | $2.33M | 7.87% |
| 1997-04-30 | $2.16M | 0.93% |
| 1996-04-30 | $2.14M | - |
Champions Oncology generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Champions Oncology Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-07-31 | - | -100.00% |
| 2024-04-30 | $14.00M | 16.49% |
| 2024-01-31 | $12.02M | 3.85% |
| 2023-10-31 | $11.57M | -7.87% |
| 2023-07-31 | $12.56M | -3.90% |
| 2023-04-30 | $13.07M | 2.33% |
| 2023-01-31 | $12.77M | -10.56% |
| 2022-10-31 | $14.28M | 3.90% |
| 2022-07-31 | $13.74M | 6.74% |
| 2022-04-30 | $12.88M | -2.40% |
| 2022-01-31 | $13.19M | 11.94% |
| 2021-10-31 | $11.79M | 4.74% |
| 2021-07-31 | $11.25M | 6.51% |
| 2021-04-30 | $10.56M | -2.28% |
| 2021-01-31 | $10.81M | 6.87% |
| 2020-10-31 | $10.12M | 5.97% |
| 2020-07-31 | $9.55M | 9.11% |
| 2020-04-30 | $8.75M | -2.91% |
| 2020-01-31 | $9.01M | 18.19% |
| 2019-10-31 | $7.63M | 13.18% |
| 2019-07-31 | $6.74M | -12.71% |
| 2019-04-30 | $7.72M | 20.03% |
| 2019-01-31 | $6.43M | -3.93% |
| 2018-10-31 | $6.69M | 7.52% |
| 2018-07-31 | $6.22M | 26.47% |
| 2018-04-30 | $4.92M | -3.15% |
| 2018-01-31 | $5.08M | -2.33% |
| 2017-10-31 | $5.20M | 3.38% |
| 2017-07-31 | $5.03M | 35.30% |
| 2017-04-30 | $3.72M | 4.35% |
| 2017-01-31 | $3.56M | -20.01% |
| 2016-10-31 | $4.46M | 21.44% |
| 2016-07-31 | $3.67M | 29.36% |
| 2016-04-30 | $2.84M | 11.17% |
| 2016-01-31 | $2.55M | -14.10% |
| 2015-10-31 | $2.97M | 5.28% |
| 2015-07-31 | $2.82M | -12.93% |
| 2015-04-30 | $3.24M | 77.20% |
| 2015-01-31 | $1.83M | -2.82% |
| 2014-10-31 | $1.88M | -1.57% |
| 2014-07-31 | $1.91M | -22.21% |
| 2014-04-30 | $2.46M | -33.39% |
| 2014-01-31 | $3.69M | 54.85% |
| 2013-10-31 | $2.38M | -21.09% |
| 2013-07-31 | $3.02M | 63.95% |
| 2013-04-30 | $1.84M | -36.85% |
| 2013-01-31 | $2.92M | 100.07% |
| 2012-10-31 | $1.46M | -30.77% |
| 2012-07-31 | $2.11M | 52.50% |
| 2012-04-30 | $1.38M | -42.36% |
| 2012-01-31 | $2.40M | 37.62% |
| 2011-10-31 | $1.74M | 6.55% |
| 2011-07-31 | $1.63M | 5.83% |
| 2011-04-30 | $1.54M | -44.96% |
| 2011-01-31 | $2.81M | 200.64% |
| 2010-10-31 | $933.00K | -41.69% |
| 2010-07-31 | $1.60M | -15.79% |
| 2010-04-30 | $1.90M | 156.06% |
| 2010-01-31 | $742.00K | -42.44% |
| 2009-10-31 | $1.29M | 33.99% |
| 2009-07-31 | $962.00K | 2.28% |
| 2009-04-30 | $940.54K | -10.61% |
| 2009-01-31 | $1.05M | 0.77% |
| 2008-10-31 | $1.04M | 55.12% |
| 2008-07-31 | $673.12K | 199.16% |
| 2008-04-30 | $225.00K | -75.67% |
| 2008-01-31 | $924.94K | - |
Champions Oncology generated - in revenue during Q1 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Champions Oncology Revenue Breakdown
Champions Oncology Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Apr 24 | Apr 23 | Apr 22 | Apr 21 | Apr 20 |
|---|---|---|---|---|---|
| Pharmacology Services | $47.03M | $50.71M | $46.83M | $39.47M | $31.26M |
| Personalized Oncology Services | $18.00K | $116.00K | $49.00K | $166.00K | $790.00K |
| Product and Service, Other | $3.10M | - | - | - | - |
| Other Services | - | $3.05M | $2.23M | $1.40M | $71.00K |
Champions Oncology's latest annual revenue breakdown by segment (product or service), as of Apr 24: Pharmacology Services (93.78%), Product and Service, Other (6.18%), and Personalized Oncology Services (0.04%).
Quarterly Revenue by Product
| Product/Service | Apr 24 | Jan 24 | Oct 23 | Jul 23 | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Personalized Oncology Services | $1.00K | - | - | $17.00K | - | $6.00K | $70.00K | $41.00K | - | $25.00K | - | $24.00K | $11.00K | $5.00K | $37.00K | $113.00K | $209.00K | $169.00K | $232.00K | $180.00K |
| Pharmacology Services | $13.12M | $11.18M | $10.88M | $11.86M | $12.35M | $12.12M | $13.48M | $12.76M | $12.37M | $12.62M | $11.14M | $10.70M | $9.27M | $10.74M | $10.04M | $9.41M | $8.53M | $8.84M | $7.36M | $6.53M |
| Product and Service, Other | $886.00K | $835.00K | $697.00K | $684.00K | $648.00K | $731.00K | $948.00K | $546.00K | $643.00K | $526.00K | $62.00K | $39.00K | $21.00K | - | $35.00K | $27.00K | - | - | - | - |
Champions Oncology's latest quarterly revenue breakdown by segment (product or service), as of Apr 24: Pharmacology Services (93.67%), Product and Service, Other (6.33%), and Personalized Oncology Services (0.01%).
Champions Oncology Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Apr 23 | Jan 23 | Oct 22 | Jul 22 | Apr 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Jan 21 | Oct 20 | Jul 20 | Apr 20 | Jan 20 | Oct 19 | Jul 19 | Jan 19 | Oct 18 | Jul 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Personalized Oncology Services | - | $6.00K | $70.00K | $41.00K | - | $25.00K | - | $24.00K | $11.00K | $5.00K | $37.00K | $113.00K | $209.00K | $169.00K | $232.00K | $180.00K | $416.00K | $249.00K | $359.00K |
| Pharmacology Services | $12.35M | $12.12M | $13.48M | $12.76M | $12.37M | $12.62M | $11.14M | $10.70M | $9.27M | $10.74M | $10.04M | $9.41M | $8.53M | $8.84M | $7.36M | $6.53M | $5.99M | $6.24M | $5.78M |
| Product and Service, Other | - | $648.00K | $731.00K | $948.00K | $546.00K | $643.00K | $526.00K | $62.00K | $39.00K | $21.00K | - | $35.00K | $27.00K | $26.00K | $208.00K | $89.00K | - | - | - |
Champions Oncology's latest quarterly revenue breakdown by geography, as of Apr 23: Pharmacology Services (100.00%).
Champions Oncology Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAG | Adagene | $18.11M | $833.34K |
| MOLN | Molecular Partners | $7.04M | $2.74M |
| HCWB | HCW Biologics | $2.84M | $618.85K |
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| MNOV | MediciNova | $1.00M | - |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| ANTX | AN2 Therapeutics | - | - |
| AVTE | Aerovate Therapeutics | - | - |
| CYT | Cyteir Therapeutics | - | - |
| ELYM | Eliem Therapeutics | - | - |
| ACRV | Acrivon Therapeutics | - | - |
| PRDS | Pardes Biosciences | - | - |
| CSBR | Champions Oncology | - | - |
CSBR Revenue FAQ
What is Champions Oncology’s yearly revenue?
Champions Oncology's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $53.87M, representing an increase of 9.69% compared to 2022. CSBR's yearly revenue for 2022 was $49.11M, representing an increase of 19.66% compared to 2021.
What is Champions Oncology’s quarterly revenue?
Champions Oncology's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a -100.00% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $14M, a 16.49% increase from the previous quarter (Q3 2024), and a 7.11% increase year-over-year (Q4 2023). CSBR's quarterly revenue for Q3 2024 was $12.02M, a 3.85% increase from the previous quarter (Q2 2024), and a -5.90% decrease year-over-year (Q3 2023).
What is Champions Oncology’s revenue growth rate?
Champions Oncology's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.
What are Champions Oncology’s revenue streams?
Champions Oncology's revenue streams in r 24 are Pharmacology Services, Personalized Oncology Services, and Product and Service, Other. Pharmacology Services generated $47.04M in revenue, accounting 93.78% of the company's total revenue, down -7.24% year-over-year. Personalized Oncology Services generated $18K in revenue, accounting 0.04% of the company's total revenue, down -84.48% year-over-year. Product and Service, Other generated $3.1M in revenue, accounting 6.18% of the company's total revenue
What is Champions Oncology’s main source of revenue?
For the fiscal year ending Apr 24, the largest source of revenue of Champions Oncology was Pharmacology Services. This segment made a revenue of $47.04M, representing 93.78% of the company's total revenue.